Consistent with this in vitro finding, intracranially co-injected edge-like 157 GBM spheres with core-like 1005 GBM spheres pre-infected with lentivirus encoding shRNA against CD109 (shCD109) showed diminished tumor growth compared to the edge-like 157 GBM spheres co-injected with shNT-infected core-like 1005 GBM spheres (Fig. 7j). This evidence concerns the gene CD109 and neoplasm.